MECHANISM OF INTERACTION BETWEEN NEUROPEPTIDE-Y AND ANGIOTENSIN-II IN THE RABBIT FEMORAL-ARTERY

被引:13
作者
CRESSIER, F [1 ]
CRISCIONE, L [1 ]
HOFBAUER, KG [1 ]
机构
[1] CIBA GEIGY AG,CARDIOVASC RES,CH-4002 BASEL,SWITZERLAND
关键词
NEUROPEPTIDE-Y; ANGIOTENSIN-II; VASOCONSTRICTION; 2ND-MESSENGER; FEMORAL ARTERY;
D O I
10.1016/0014-2999(94)00619-I
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuropeptide Y has direct vasoconstrictor actions and potentiates the effects of other vasoconstrictor agents. To find out whether both effects of neuropeptide Y are mediated via the same receptor and intracellular mechanism, the interaction between neuropeptide Y and angiotensin II was studied in rabbit femoral arteries. In this preparation, neuropeptide Y, but not its 13-36 fragment, induced constriction. Only neuropeptide Y potentiated the vasoconstrictor response to angiotensin II and the associated rise in inositol-1-phosphate. These potentiating effects of neuropeptide Y were totally prevented by removal of extracellular Ca2+, partially prevented by a Ca2+-channel blocker and mimicked by a Ca2+-channel activator. Pharmacological modulation of adenylate cyclase had no effect. These results suggest that the direct and indirect vascular effects of neuropeptide Y are mediated via Y-1 receptors and depend on the influx of extracellular Ca2+. The rise in inositol-l-phosphate seems to be secondary to an increase in intracellular Ca2+, while modulation of adenylate cyclase is apparently not involved.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 43 条
[1]   Y1 RECEPTORS FOR NEUROPEPTIDE-Y ARE COUPLED TO MOBILIZATION OF INTRACELLULAR CALCIUM AND INHIBITION OF ADENYLATE-CYCLASE [J].
AAKERLUND, L ;
GETHER, U ;
FUHLENDORFF, J ;
SCHWARTZ, TW ;
THASTRUP, O .
FEBS LETTERS, 1990, 260 (01) :73-78
[2]  
ABEL PW, 1989, J CARDIOVASC PHARM, V13, P52
[3]   BLOCKADE OF NEUROPEPTIDE Y-INDUCED POTENTIATION OF NORADRENALINE-EVOKED VASOCONSTRICTION BY D-MYO-INOSITOL-1.2.6-TRISPHOSPHATE(PP56) IN RABBIT FEMORAL ARTERIES [J].
ADAMSSON, M ;
EDVINSSON, L .
NEUROPEPTIDES, 1991, 19 (01) :13-16
[4]  
ANDRIANTSITOHAI.R, 1988, BRIT J PHARMACOL, V95, P419
[5]   INOSITOL TRISPHOSPHATE AND DIACYLGLYCEROL AS 2ND MESSENGERS [J].
BERRIDGE, MJ .
BIOCHEMICAL JOURNAL, 1984, 220 (02) :345-360
[6]   SARMESIN IS A PARTIAL AGONIST OF ANGIOTENSIN-II RECEPTORS IN RABBIT, BUT NOT IN RAT, AORTIC RINGS [J].
CRISCIONE, L ;
THOMANN, H ;
WHITEBREAD, S ;
DEGASPARO, M ;
KAMBER, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (02) :636-642
[7]   BLOCKADE OF ENDOTHELIN-INDUCED CONTRACTIONS BY DICHLOROBENZAMIL - MECHANISM OF ACTION [J].
CRISCIONE, L ;
THOMANN, H ;
RODRIGUEZ, C ;
EGLEME, C ;
CHIESI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (01) :247-254
[8]   THE ROLE OF NEUROPEPTIDE-Y IN VASCULAR SYMPATHETIC NEUROTRANSMISSION MAY BE ENHANCED IN HYPERTENSION [J].
DALY, RN ;
ROBERTS, MI ;
RUFFOLO, RR ;
HIEBLE, JP .
JOURNAL OF HYPERTENSION, 1988, 6 :S535-S538
[9]   NEUROPEPTIDE-Y MOBILIZES INTRACELLULAR CA2+ AND INCREASES INOSITOL PHOSPHATE PRODUCTION IN HUMAN ERYTHROLEUKEMIA-CELLS [J].
DANIELS, AJ ;
LAZAROWSKI, ER ;
MATTHEWS, JE ;
LAPETINA, EG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1138-1144
[10]   ENDOTHELIUM MODULATES THE EFFECTS OF ALPHA-ADRENOCEPTOR AGONISTS IN VASCULAR SMOOTH-MUSCLE [J].
DEMIREL, E ;
HINDIOGLU, F ;
ERCAN, ZS ;
TURKER, RK .
GENERAL PHARMACOLOGY, 1989, 20 (01) :89-93